DE | EN | ES

News and press releases from HAPILA

Chemspec Europe 31 May - 1 June 2017, Munich

The value chain of organic fine chemicals and active ingredient production at one stand Eight companies from East Germany will present their expertise together at one stand at Chemspec Europe 2017 in Munich. With their broad...[more]

API Manufacture Using Green Electricity from January

Due to the conclusion of a new energy supply contract between HAPILA GmbH and Thüringer Energie AG (TEAG), the Thuringian Energy public limited company, green current will flow at HAPILA from January 2017. Ms Annegret Noth and Mr...[more]

CPhI Worldwide 2016 in Barcelona

"CPhI is an established pharmaceutical event with over 26 years' experience of bringing together the movers and shakers in pharma."This year the CPhI Worldwide exhibition takes place from 4th-6th October, 2016 at the...[more]

Strategic Advisory Board is Extended

In the course of this year‘s 7th conference the advisory board of HAPILA GmbH was extended. It means a great pleasure to us to welcome Prof. Dr. Dr. Gerhard Strugala as a new member of the advisory board. We hope for additional...[more]

US Patent for Counter-current Crystallization HAPIpur®

Effective from 4 August 2015, we have been granted the US patent with the registration number US 9,095,783 "Arrangement and method for producing high-purity crystals" by the American patent office "United States...[more]

Come and see us at the CPhl 2015 in Madrid

HAPILA GmbH participates in the CPhl Worldwide this year as an exhibitor for the eighth time. We invite you to see us at our stall 9C11 to talk to us about existing or new projects concerning development and GMP manufacture in...[more]

CEP Grant by the European Medicines Agency

Recently the EDQM (European Directorate for the Quality of Medicines & Health Care, headquarters in Strasbourg) granted us the Certificate of suitability No. R0-CEP 2013-277 (Certification of suitability of Monographs of the...[more]

Displaying results 15 to 21 out of 25